Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Change in Account Payables (2021 - 2026)

Alvotech's (ALVO) quarterly Change in Account Payables came in at $30.7 million in Q2 2026, up 120.08% on a YoY basis from $13.9 million in Q2 2025, and up 189.4% quarter-over-quarter from -$34.3 million in Q1 2026.

Analysis

Alvotech (ALVO) Change in Account Payables (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Change in Account Payables for 6 consecutive years, with $30.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Account Payables rose 120.08% year-over-year to $30.7 million; the trailing twelve-month figure through Jun 2026 stood at $23.9 million (up 1229.66% YoY), and the FY2025 full-year result was $45.3 million, up 430.87% from the prior year.
  • Change in Account Payables rose to $30.7 million in Q2 2026 per ALVO's latest filing, from -$34.3 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $73.2 million in Q4 2025 and bottomed at -$45.7 million in Q3 2025.
  • Historically, Change in Account Payables has averaged $4.3 million across 5 years, with a median of $6.9 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Change in Account Payables jumped 634.86% in 2025, then plunged 1001.76% in 2026.
  • Over 5 years, Change in Account Payables stood at $6.6 million in 2022, then surged by 393.11% to $32.3 million in 2023, then plunged by 142.35% to -$13.7 million in 2024, then surged by 634.86% to $73.2 million in 2025, then plunged by 58.09% to $30.7 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $30.7 million, -$34.3 million, and $73.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -21.20 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 45.25 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -8.53 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 30.70 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -1.12 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.70 Mn
Mar 31, 2026 -34.34 Mn
Dec 31, 2025 73.25 Mn
Sep 30, 2025 -45.69 Mn
Jun 30, 2025 13.95 Mn
Mar 31, 2025 3.81 Mn
Dec 31, 2024 -13.70 Mn
Sep 30, 2024 -6.18 Mn
Jun 30, 2024 7.17 Mn
Mar 31, 2024 -28.93 Mn
Dec 31, 2023 32.34 Mn
Jun 30, 2023 12.42 Mn
Dec 31, 2022 6.56 Mn
Jun 30, 2022 8.87 Mn
Dec 31, 2021 2.89 Mn
Sep 30, 2021 3.72 Mn